• Return to Headlines

Uptrend Call Working As Intra-Cellular T Stock Rises 50.4% (ITCI)

By David Diaz

SmarTrend identified an Uptrend for Intra-Cellular T (NASDAQ:ITCI) on June 26th, 2017 at $12.41. In approximately 2 months, Intra-Cellular T has returned 50.44% as of today's recent price of $18.67.

In the past 52 weeks, Intra-Cellular T share prices have been bracketed by a low of $7.85 and a high of $45.20 and are now at $18.67, 138% above that low price. The 200-day and 50-day moving averages have moved 0.06% higher and 0.67% higher over the past week, respectively.

Intra-Cellular Therapies Inc. researches and develops biopharmaceutical drugs. The Company engages in the research and development of small molecule drugs to treat neuropsychiatric and neurological diseases and other disorders of the central nervous system. Intra-Cellular Therapies offers its products to the medical industry.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Intra-Cellular T shares.

Log in and add Intra-Cellular T (ITCI) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights intra-cellular t

Ticker(s): ITCI